Darbepoetin for the anaemia of chronic kidney disease

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

We will evaluate the benefits and harms of darbepoetin alpha compared with other ESAs, placebo, or no treatment in individuals with CKD.

Ancillary